combination

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

5 days ago
Hollyland introduces the all-new LARK A1 wireless microphone, the perfect combination of professional sound quality and high valueHollyland introduces the all-new LARK A1 wireless microphone, the perfect combination of professional sound quality and high value

Hollyland introduces the all-new LARK A1 wireless microphone, the perfect combination of professional sound quality and high value

The gateway to professional audio starts at $34.9. SHENZHEN, China, May 27, 2025 /PRNewswire/ -- Hollyland, a leading provider of…

2 weeks ago